Comment on 'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19': involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19.

Shiohara, T; Mizukawa, Y

Shiohara, T; Mizukawa, Y.

Shiohara T; Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
Mizukawa Y; Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.

J Eur Acad Dermatol Venereol ; 35(2): e98-e100, 2021 02.

Article in English | MEDLINE | ID: covidwho-793471

Subject(s)

COVID-19; Drug Hypersensitivity Syndrome; Eosinophilia; Drug Hypersensitivity Syndrome/etiology; Eosinophilia/chemically induced; Humans; SARS-CoV-2; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Eosinophilia / Drug Hypersensitivity Syndrome / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2021 Document Type: Article Affiliation country: Jdv.16959

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google